CTF citrofresh international limited

BIT has better prospects IMO: Sydney - Thursday - September 8:...

  1. 56,874 Posts.
    lightbulb Created with Sketch. 286
    BIT has better prospects IMO:

    Sydney - Thursday - September 8: (RWE Aust Business News) -
    Biotron Ltd (ASX:BIT) has had a lead compound selected for clinical
    trials in HIV treatment.
    The trials of the selected drug BIT225 are expected to commence
    in the first half of 2006.
    Biotron shares were up 3c at 19c
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.